329 related articles for article (PubMed ID: 9341902)
1. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
Wulf GG; Jürgens B; Liersch T; Gatzemeier W; Rauschecker H; Buske C; Hüfner M; Hiddemann W; Wörmann B
J Cancer Res Clin Oncol; 1997; 123(9):514-21. PubMed ID: 9341902
[TBL] [Abstract][Full Text] [Related]
2. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
3. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.
Miyajima Y; Kato K; Numata S; Kudo K; Horibe K
Cancer; 1995 Jun; 75(11):2757-61. PubMed ID: 7743482
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
[TBL] [Abstract][Full Text] [Related]
5. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
[TBL] [Abstract][Full Text] [Related]
6. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis.
Bouizar Z; Spyratos F; De vernejoul MC
J Bone Miner Res; 1999 Mar; 14(3):406-14. PubMed ID: 10027905
[TBL] [Abstract][Full Text] [Related]
7. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
[TBL] [Abstract][Full Text] [Related]
8. Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene.
Bossolasco P; Ricci C; Farina G; Soligo D; Pedretti D; Scanni A; Deliliers GL
Cancer Detect Prev; 2002; 26(1):60-3. PubMed ID: 12088204
[TBL] [Abstract][Full Text] [Related]
9. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C
Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779
[TBL] [Abstract][Full Text] [Related]
10. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19.
Zhong XY; Kaul S; Lin YS; Eichler A; Bastert G
J Cancer Res Clin Oncol; 2000 Apr; 126(4):212-8. PubMed ID: 10782894
[TBL] [Abstract][Full Text] [Related]
11. Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase/polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products.
Zhong XY; Kaul S; Diel I; Eichler A; Bastert G
J Cancer Res Clin Oncol; 1999; 125(5):286-91. PubMed ID: 10359133
[TBL] [Abstract][Full Text] [Related]
12. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.
Slade MJ; Smith BM; Sinnett HD; Cross NC; Coombes RC
J Clin Oncol; 1999 Mar; 17(3):870-9. PubMed ID: 10071278
[TBL] [Abstract][Full Text] [Related]
13. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
14. Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis.
Cheung IY; Sahota A; Cheung NK
Cancer; 2004 Nov; 101(10):2303-8. PubMed ID: 15484213
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival.
Linforth R; Anderson N; Hoey R; Nolan T; Downey S; Brady G; Ashcroft L; Bundred N
Clin Cancer Res; 2002 Oct; 8(10):3172-7. PubMed ID: 12374685
[TBL] [Abstract][Full Text] [Related]
16. Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.
Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
Br J Cancer; 2006 Mar; 94(5):672-80. PubMed ID: 16495933
[TBL] [Abstract][Full Text] [Related]
17. Detection of bone marrow-disseminated breast cancer cells using an RT-PCR assay of MUC5B mRNA.
Berois N; Varangot M; Sóñora C; Zarantonelli L; Pressa C; Laviña R; Rodríguez JL; Delgado F; Porchet N; Aubert JP; Osinaga E
Int J Cancer; 2003 Feb; 103(4):550-5. PubMed ID: 12478674
[TBL] [Abstract][Full Text] [Related]
18. Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene.
Luppi M; Morselli M; Bandieri E; Federico M; Marasca R; Barozzi P; Ferrari MG; Savarino M; Frassoldati A; Torelli G
Ann Oncol; 1996 Aug; 7(6):619-24. PubMed ID: 8879377
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of MUC1 and EGP40 in bone marrow and peripheral blood as a marker for occult breast cancer.
Zhong XY; Kaul S; Bastert G
Arch Gynecol Obstet; 2001 Jan; 264(4):177-81. PubMed ID: 11205703
[TBL] [Abstract][Full Text] [Related]
20. Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients.
Krüger W; Krzizanowski C; Holweg M; Stockschläder M; Kröger N; Jung R; Mross K; Jonat W; Zander AR
J Cancer Res Clin Oncol; 1996; 122(11):679-86. PubMed ID: 8898979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
